Boston Scientific’s Q3 2023 earnings report highlights significant growth in cardiology, with year-to-date U.S. growth at 27%, driven by successful product launches and innovation.
SBA Communications’ Q3 2024 results reveal significant strategic growth in Central America despite mixed financial performance, including a 199.6% rise in net income.
